Related Experiment Video
Updated: Oct 18, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Follow-up after acute thrombotic events following COVID-19 infection
Christopher M Faries1, Ajit Rao1, Nicole Ilonzo1
1Department of Surgery, Division of Vascular Surgery, New York, NY.
Insights
COVID-19 infection causes blood clots, leading to high mortality and complication rates in patients experiencing arterial thrombotic events. Follow-up revealed poor outcomes and low patency rates for treated patients.
Area of Science:
- Vascular Surgery
- Infectious Diseases
- Cardiology
Background:
- COVID-19 infection is associated with a hypercoagulable state.
- Thrombotic events are a significant complication in patients with COVID-19.
Purpose of the Study:
- To report the 3- and 6-month follow-up of patients with acute arterial thrombotic events secondary to COVID-19 infection.
- To evaluate outcomes, including mortality, patency rates, and limb salvage, in this patient cohort.
Main Methods:
- Prospective data collection of vascular surgery consultations for patients with COVID-19 presenting with arterial thrombotic events.
- Analysis of treatment strategies including open surgical intervention, endovascular intervention, and anticoagulation.
- Assessment of 3- and 6-month follow-up data for mortality, primary patency, and limb salvage rates.
Main Results:
- Twenty-seven patients experienced acute arterial thrombotic events.
- At 6 months, 48.0% of patients were deceased, with a cumulative primary patency rate of 61.9%.
- The limb-salvage rate at 6 months was 89.2%.
Conclusions:
- Patients with COVID-19 experiencing thrombotic events face high mortality and complication rates.
- Intervention outcomes were characterized by relatively low patency rates.
- Vigilant monitoring and management strategies are crucial for this high-risk patient group.
Objective:
COVID-19 infection results in a hypercoagulable state predisposing patients to thrombotic events. We report the 3- and 6-month follow-up of 27 patients who experienced acute arterial thrombotic events in the setting of COVID-19 infection.
Methods:
Data were prospectively collected and maintained for all vascular surgery consultations in the Mount Sinai Health System from patients who presented between March 16 and May 5, 2020.
Results:
Twenty-seven patients experienced arterial thrombotic events. The average length of stay was 13.3 ± 15.4 days. Fourteen patients were treated with open surgical intervention, six were treated with endovascular intervention, and seven were treated with anticoagulation only. At 3-month follow-up, 11 patients (40.7%) were deceased. Nine patients who expired did so during the initial hospital stay. The 3-month cumulative primary patency rate for all interventions was 72.2%, and the 3-month primary patency rates for open surgical and endovascular interventions were 66.7 and 83.3, respectively. There were 9 (33.3%) readmissions within 3 months. Six-month follow-up was available in 25 (92.6%) patients. At 6-month follow-up, 12 (48.0%) patients were deceased, and the cumulative primary patency rate was 61.9%. The 6-month primary patency rates of open surgical and endovascular interventions were 66.7% and 55.6%, respectively. The limb-salvage rate at both 3 and 6 months was 89.2%.
Conclusions:
Patients with COVID-19 infections who experienced thrombotic events saw high complication and mortality rates with relatively low patency rates.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Endocarditis III: Medical Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Myocarditis III: Medical Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

